Research & Development (R&D)

Lupin’s Inhalation Research Center, Florida receives EIR from U.S. FDA

Mumbai, March 30, 2020: Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the…

5 years ago

Cadila Pharma accredited as Authorized Economic Operator

Cadila Pharmaceuticals  recognized as the Authorized Economic Operator (AEO) by the Central Board of Indirect Taxes and Customs. Ahmedabad, July…

5 years ago

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

Shanghai, July 23, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit…

5 years ago

Dr. Reddy’s Laboratories announces the launch of Ramelteon Tablets, in the U.S. Market

Hyderabad, July 23, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together…

5 years ago

Eisai’s Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China

Tokyo, July 17, 2019: Eisai has received a New Drug Approval for its in-house developed anticancer agent Halaven (eribulin mesylate)…

5 years ago

Eisai Center for Genetics Guided Dementia Discovery Commences Full-Scale Operation Toward Innovative Dementia Treatments With New Drug Discovery Approach in Cambridge, Massachusetts

A Focused Drug Discovery Approach That Integrates Human Genetics/ Data Science/ Precision Chemistry Tokyo, July 10, 2019: Eisai Co., Ltd.…

5 years ago

Dr. Reddy’s Laboratories announces entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC

Hyderabad, June 14, 2019: Dr. Reddy's Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announces that it has entered into…

5 years ago

AstraZeneca opens dedicated Development Operations office in Bengaluru to support expansion of its clinical research footprint in India

The Development Operations Centre supports the development of AstraZeneca’s innovative medicines and hosts clinical trial experts focused on core therapeutic…

5 years ago

TRIGR Therapeutics Announces Formation of Global Clinical & Scientific Advisory Board

New Delhi, May 19, 2019: TRIGR Therapeutics, Inc. ("TRIGR"), a clinical stage biotechnology company focused on the development of multi-targeted and…

6 years ago